Detalhe da pesquisa
1.
B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma.
Haematologica
; 108(12): 3347-3358, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37139600
2.
Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patients.
Eur J Immunol
; 51(6): 1449-1460, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33788264
3.
IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination.
N Engl J Med
; 387(16): 1524-1527, 2022 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36130012
4.
Impact of vincristine dose reduction on outcomes of patients with aggressive B-cell lymphoma treated with (R)-CHOP.
Haematologica
; 108(10): 2844-2849, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36815369
5.
Report on the Second PANLAR Review Course in Rheumatology: Biosimilars Update.
J Clin Rheumatol
; 26(1): 33-36, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30273265
6.
Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas.
Sci Rep
; 14(1): 9571, 2024 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38671086
7.
Vitamin D Enhances Immune Effector Pathways of NK Cells Thus Providing a Mechanistic Explanation for the Increased Effectiveness of Therapeutic Monoclonal Antibodies.
Nutrients
; 15(16)2023 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37630689
8.
Ars2-containing bispecific, Fab- and IgG1-format BAR-bodies to target DLBCL cells.
EJHaem
; 4(1): 125-134, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36819155
9.
Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives.
Cancers (Basel)
; 14(12)2022 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35740684
10.
Biomarker guided treatment in oncogene-driven advanced non-small cell lung cancer in older adults: A Young International Society of Geriatric Oncology report.
J Geriatr Oncol
; 13(8): 1071-1083, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35525790
11.
Adaptive humoral immune response and cellular immune status in cancer patients and patients under immunosuppression vaccinated against SARS-CoV-2.
Expert Rev Vaccines
; 21(11): 1683-1689, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35994606
12.
Autoantibodies against SUMO1-DHX35 in long-COVID.
J Transl Autoimmun
; 5: 100171, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36425003
13.
Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study.
Lancet Rheumatol
; 4(5): e329-e337, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35368387
14.
Advances in Lymphoma Molecular Diagnostics.
Diagnostics (Basel)
; 11(12)2021 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34943410
15.
Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019.
Intensive Care Med Exp
; 9(1): 45, 2021 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34476598
16.
Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab.
Front Oncol
; 10: 1578, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32984017
17.
Benzbromarone in the treatment of gout.
Adv Rheumatol
; 59(1): 37, 2019 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31391099
18.
The biosimilars journey: current status and ongoing challenges.
Drugs Context
; 7: 212543, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30302115
19.
Partnership for productive development of biosimilar products: perspectives of access to biological products in the Brazilian market.
Einstein (Sao Paulo)
; 16(3): eRW4175, 2018 Sep 17.
Artigo
em Inglês, Português
| MEDLINE | ID: mdl-30231147
20.
The Experience with Biosimilars of Infliximab in Rheumatic Diseases.
Curr Pharm Des
; 23(44): 6752-6758, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29189135